Cargando…

The Portuguese generic medicines market: a policy analysis

OBJECTIVES: This study aims to conduct a descriptive analysis of the policy environment surrounding the generic medicines retail market in Portugal. The policy analysis focuses on supply-side measures (i.e. market access, pricing, reference-pricing and reimbursement of generic medicines) and demand-...

Descripción completa

Detalles Bibliográficos
Autor principal:	Simoens, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas 2009
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139743/ https://www.ncbi.nlm.nih.gov/pubmed/25152781

Ejemplares similares

Generic Medicine Pricing Policies in Europe: Current Status and Impact
por: Dylst, Pieter, et al.
Publicado: (2010)

Analysis of the Korean generic medicine market: Factors affecting the market share of generic medicines
por: Kim, Dong‐Sook, et al.
Publicado: (2021)

How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing?
por: Dylst, Pieter, et al.
Publicado: (2012)

Analysis of the evolution of the price of oncology drugs after the loss of their patent and the marketing of generic medicines
por: Martínez-Sesmero, José M., et al.
Publicado: (2022)

Reshaping Australian drug policy: the dilemmas of generic medicines policy
por: Löfgren, Hans
Publicado: (2007)

New pricing models for generic medicines to ensure long-term sustainable competition in Europe
por: Francois, Clement, et al.
Publicado: (2023)

Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
por: Vandenplas, Yannick, et al.
Publicado: (2021)

The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use
por: Hassali, Mohamed Azmi, et al.
Publicado: (2013)

Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets
por: Jang, Minyoung, et al.
Publicado: (2020)

Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs
por: Hammami, Muhammad M., et al.
Publicado: (2017)

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2—Biosimilar and Originator Etanercept in the Outpatient Setting
por: Moorkens, Evelien, et al.
Publicado: (2019)

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1—Biosimilar and Originator Infliximab in the Hospital Setting
por: Moorkens, Evelien, et al.
Publicado: (2019)

The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape
por: Moorkens, Evelien, et al.
Publicado: (2017)

The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis
por: Vandenplas, Yannick, et al.
Publicado: (2023)

Policies and Practices Catalyzing the Use of Generic Medicines: A Systematic Search and Review
por: Mostafa, Shahmoradi, et al.
Publicado: (2021)

Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
por: Kwon, Hye-Young, et al.
Publicado: (2016)

Trans fatty acids in the Portuguese food market
por: Costa, Nádia, et al.
Publicado: (2016)

Drugs Becoming Generics—The Impact of Genericization on the Market Performance of Antihypertensive Active Pharmaceutical Ingredients
por: Kovács, Bence, et al.
Publicado: (2021)

Brazilian generics market change after Farmácia Popular program
por: Bertoldi, Andréa Dâmaso, et al.
Publicado: (2019)

Market access of orphan drugs and the role of multi-criteria decision making
por: Simoens, Steven
Publicado: (2012)

Post-Marketing Surveillance of a generic Oxaliplatin (Alvoxal(Ⓡ)) in Iranian Patients with Cancer
por: Shahi, Farhad, et al.
Publicado: (2021)

Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland
por: O’Leary, A., et al.
Publicado: (2015)

Comparison of Generic Drug Reviews for Marketing Authorization between Japan and Canada
por: Kuribayashi, Ryosuke, et al.
Publicado: (2017)

Emerging Insights into European Markets of Biologics, Including Biosimilars
por: Simoens, Steven, et al.
Publicado: (2022)

Classification of Pharmaceutical Policy Measures During the Portuguese Financial Crisis
por: Donato, António Augusto, et al.
Publicado: (2022)

Generic Medicine and Generic Prescribing in Nepal: An Implication for Policymakers
por: Shrestha, Rajeev, et al.
Publicado: (2022)

ENTRY IN THE ADHD DRUGS MARKET: WELFARE IMPACT OF GENERICS AND ME-TOO'S*
por: Bokhari, Farasat A S, et al.
Publicado: (2013)

Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trends
por: Car, Elif, et al.
Publicado: (2023)

Time to Marketing of Generic Drugs After Patent Expiration in Canada
por: Lexchin, Joel
Publicado: (2021)

Determination of trace metals in fruit juices in the Portuguese market
por: Anastácio, Mariana, et al.
Publicado: (2018)

Patients’ beliefs about generic medicines in Malaysia
por: Wong, Zhi Y., et al.
Publicado: (2014)

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2014)

New Product Development in the Pharmaceutical Industry: Evidence from a generic market
por: Yousefi, Nazila, et al.
Publicado: (2017)

A Retrospective Analysis of Applications for Registration of Generic Medicines Processed by the Medicines Control Authority of Zimbabwe
por: Samunda, Brilliant Tinashe, et al.
Publicado: (2022)

Erratum to: Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
por: Kwon, Hye-Young, et al.
Publicado: (2017)

The long-term effect of generic price competition on the Hungarian statin market
por: Répásy, Balázs, et al.
Publicado: (2023)

Evaluation of the effects of a generic substitution policy implemented in Chile
por: Mansilla, Cristián, et al.
Publicado: (2019)

Does Portuguese pharmaceutical market follow an innovative trend? The INFOMED database analysis
por: Avelar, FG, et al.
Publicado: (2022)

Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
por: WOUTERS, OLIVIER J., et al.
Publicado: (2017)

R&D Costs of New Medicines: A Landscape Analysis
por: Simoens, Steven, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_484rn7vb0t80afsp7kuc9hldnd